DIPSS-plus improves outcome prediction after allogeneic haematopoietic stem cell transplantation (HSCT) for myelofibrosis

被引：0
|
作者：
Ditschkowski, M. [1 ]
Elmaagacli, A. H. [1 ]
Steckel, N. K. [1 ]
Gromke, T. [1 ]
Trenschel, R. [1 ]
Koldehoff, M. [1 ]
Beeen, D. W. [1 ]
机构：
[1] Univ Hosp Essen, Essen, Germany
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S15 / S16
页数：2
相关论文
共 50 条
  • [31] Common oral diseases in allogeneic haematopoietic stem cell transplantation (HSCT) recipients pre-HSCT
    Uutela, Pauliina
    Passweg, Jakob
    Halter, Jorg
    Weiger, Roland
    Waltimo, Tuomas
    Mauramo, Matti
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (04) : 351 - 356
  • [32] Allogeneic haematopoietic stem cell transplantation for primary myelofibrosis and myelofibrosis evolved from other myeloproliferative neoplasms
    Tamari, Roni
    Castro-Malaspina, Hugo
    CURRENT OPINION IN HEMATOLOGY, 2015, 22 (02) : 184 - 190
  • [33] Unrelated allogeneic hematopoietic stem cell transplantation (HSCT) for myelofibrosis with myeloid metaplasia (MMM)
    Koldehoff, M
    Basara, N
    Lentini, G
    Pohl, H
    Kiehl, MG
    Fauser, AA
    BONE MARROW TRANSPLANTATION, 2002, 29 : S166 - S166
  • [34] Allogeneic haematopoietic stem cell transplantation (allo-HSCT)-associated pneumatosis intestinalis
    Shapira, M. Y.
    Avni, B.
    Grisariu, S.
    Resnick, I. B.
    Or, R.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S359 - S359
  • [35] Allogeneic Stem Cell Transplantation in Myelofibrosis
    Jain, Tania
    Mesa, Ruben A.
    Palmer, Jeanne M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (09) : 1429 - 1436
  • [36] Incidence, mortality and biological characteristics of bronchiolitis obliterans (BO) after allogeneic haematopoietic stem cell transplantation (HSCT)
    Ditschkowski, M.
    Gromke, M.
    Elmaagacli, A. H.
    Steckel, N. K.
    Koldehoff, M.
    Beelen, D. W.
    ONKOLOGIE, 2012, 35 : 199 - 200
  • [37] Alemtuzumab based reduced intensity conditioning allogeneic haematopoietic stem cell transplantation for myelofibrosis
    Nagi, W.
    Lim, Z. Y.
    Krishnamurthy, P.
    Potter, V.
    Tindell, V.
    Reiff-Zall, L.
    Abdullah, A.
    Lea, N.
    Kenyon, M.
    Marsh, J.
    Ho, A. Y. L.
    Mufti, G. J.
    Pagliuca, A.
    LEUKEMIA RESEARCH, 2011, 35 (08) : 998 - 1000
  • [38] Allogeneic haematopoietic stem cell transplantation in patient with primary myelofibrosis and splanchnic vein thrombosis
    Barabanshikova, Maria
    Morozova, Elena
    Vlasova, Julia
    Moiseev, Ivan
    Pirogova, Olga
    Baikov, Vadim
    Shvetsov, Alexander
    Smirnov, Alexander
    Darskaya, Elena
    Afanasyev, Boris
    BONE MARROW TRANSPLANTATION, 2019, 54 : 208 - 208
  • [39] No influence of V617F mutation in JAK2 on outcome after allogeneic hematopoietic stem cell transplantation (HSCT) for myelofibrosis
    Ditschkowski, Markus
    Elmaagacli, Ahmet H.
    Trenschel, Rudolf
    Steckel, Nina K.
    Koldehoff, Michael
    Beelen, Dietrich W.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (12) : 1350 - 1351
  • [40] Relapse of acute leukemia after allogeneic haematopoietic stem cell transplantation (HSCT): Combination of pharmacological and cellular approach
    Boncompagni, Riccardo
    Cutini, Ilaria
    Nardini, Carlo
    Guidi, Stefano
    Gozzini, Antonella
    Nozzoli, Chiara
    Saccardi, Riccardo
    BONE MARROW TRANSPLANTATION, 2019, 54 : 153 - 154
12345